BMJ  2008;336:1174-1177 (24 May), doi:10.1136/bmj.39534.571644.BE (published 17 April 2008)

Research

Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial

¹ Department of Clinical Chemistry, Altnagelvin Hospital, Western Health and Social Care Trust, Londonderry, Northern Ireland, ² Psychology Research Institute, University of Ulster, Londonderry, Northern Ireland, ³ Institute of Nursing Research, University of Ulster, Coleraine, Northern Ireland

Objectives To assess the effect of self monitoring of blood glucose concentrations on glycaemic control and psychological indices in patients with newly diagnosed type 2 diabetes mellitus.

Design Prospective randomised controlled trial of self monitoring versus no monitoring (control).

Setting Hospital diabetes clinics.

Participants 184 (111 men) people aged <70 with newly diagnosed type 2 diabetes referred to the participating diabetes clinics. Major exclusion criteria were secondary diabetes, insulin treatment, previous self monitoring of blood glucose.

Interventions Participants were randomised to self monitoring or no monitoring (control) groups for one year with follow-up at three monthly intervals. Both groups underwent an identical structured core education programme. The self monitoring group received additional education on monitoring.

Main outcome measures Between group differences in HbA_1c, psychological indices, use of oral hypoglycaemic drugs, body mass index (BMI), and reported hypoglycaemia rates.

Results 96 patients (55 men) were randomised to monitoring and 88 (56 men) to control. There were no baseline differences in mean (SD) age (57.7 (11.0) in monitoring group v 60.9 (11.5) in control group) or HbA_1c (8.8 (2.1)% v 8.6 (2.3)%, respectively). Those in the monitoring group had a higher baseline BMI (34 (7) v 32 (6.2)). There were no significant differences between groups at any time point (12 months values given) in HbA_1c (6.9 (0.8)% v 6.9 (1.2)%, P=0.69; 95% confidence interval for difference –0.25% to 0.38%), BMI (33.1 (6.4) v 31.8 (6.0); adjusted for baseline BMI, P=0.32), use of oral hypoglycaemic drugs, or reported incidence of hypoglycaemia. Monitoring was associated with a 6% higher score on the depression subscale of the well-being questionnaire (P=0.01).

Conclusions In patients with newly diagnosed type 2 diabetes self monitoring of blood glucose concentration has no effect on glycaemic control but is associated with higher scores on a depression subscale.

Trial registration ISRCTN 49814766.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Why patients who self monitor glucose might be more depressed

Lucy M Candib
BMJ 2008 336: 1263-1264. [Extract] [Full Text] [PDF]

Self monitoring of blood glucose in type 2 diabetes

Martin Gulliford
BMJ 2008 336: 1139-1140. [Extract] [Full Text] [PDF]

Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives

Elizabeth Peel, Margaret Douglas, and Julia Lawton
BMJ 2007 335: 493. [Abstract] [Full Text] [PDF]

Self monitoring of blood glucose in type 2 diabetes

Simon R Heller
BMJ 2007 335: 105-106. [Extract] [Full Text] [PDF]

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial

Andrew Farmer, Alisha Wade, Elizabeth Goyder, Patricia Yudkin, David French, Anthea Craven, Rury Holman, Ann-Louise Kinmonth, and Andrew Neil
BMJ 2007 335: 132. [Abstract] [Full Text] [PDF]

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Irene M Stratton, Amanda I Adler, H Andrew W Neil, David R Matthews, Susan E Manley, Carole A Cull, David Hadden, Robert C Turner, and Rury R Holman
BMJ 2000 321: 405-412. [Abstract] [Full Text] [PDF]

Comparison of blood or urine testing by patients with newly diagnosed non-insulin dependent diabetes: patient survey after randomised crossover trial

Pat Miles, Joan Everett, June Murphy, and David Kerr
BMJ 1997 315: 348-349. [Full Text]

This article has been cited by other articles:

• Candib, L. M (2008). Why patients who self monitor glucose might be more depressed. BMJ 336: 1263-1264 [Full text]  
• Gulliford, M. (2008). Self monitoring of blood glucose in type 2 diabetes. BMJ 336: 1139-1140 [Full text]  

Rapid Responses:

Read all Rapid Responses

Mean weekly glycemia: a SMBG-derived method for near-real-time evaluation of glycemic control and of adequacy of treatment strategy

AUGUSTO PIMAZONI, MD
bmj.com, 20 Apr 2008 [Full text]

why self-monitoring patients might score higher in depression

Lucy M. Candib
bmj.com, 20 Apr 2008 [Full text]

Merely proves there is no point in home monitoring if you ignore the results

Ben L Balzer
bmj.com, 26 Apr 2008 [Full text]

Ignoring the obvious

Patti D Evans
bmj.com, 24 Aug 2008 [Full text]